Equities researchers at StockNews.com started coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Free Report) (TSE:AEZ) in a research note issued to investors on Sunday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock.
Aeterna Zentaris Stock Performance
Shares of NASDAQ:AEZS opened at $3.29 on Friday. The firm has a 50 day simple moving average of $2.89 and a 200 day simple moving average of $3.25. Aeterna Zentaris has a 52 week low of $3.96 and a 52 week high of $12.00. The company has a market cap of $5.90 million, a PE ratio of -0.22 and a beta of 1.55.
About Aeterna Zentaris
Featured Stories
- Five stocks we like better than Aeterna Zentaris
- Stock Splits, Do They Really Impact Investors?
- Can TikTok Stock Picks Really Make You Rich?
- What Are Dividends? Buy the Best Dividend Stocks
- The “Quality” Rotation: Back to Basics Investing
- The 3 Best Fintech Stocks to Buy Now
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for Aeterna Zentaris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aeterna Zentaris and related companies with MarketBeat.com's FREE daily email newsletter.